Delivery of therapeutic molecules into the CNS

Progress in Brain Research

Volumn 128, Issue , 2000, Pages 323-332

  Emborg, Marina E ^a   Kordower, Jeffrey H ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; MICROSPHERE;

ACTIVE TRANSPORT; BLOOD BRAIN BARRIER; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DIFFUSION; GENE DELIVERY SYSTEM; GENE THERAPY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; TIGHT JUNCTION;

EID: 0034589390     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(00)28029-1     Document Type: Conference Paper

References (85)

1. Albeck, D.S., Hoffer, B.J., Quissell, D., Sanders, L.A., Zerbe, G. and Granholm, A.C. (1997) A non-invasive transport system for GDNF across the blood-brain barrier. NeuroReport, 8: 2293-2298.
2. Alyautdin, R.N., Petrov, V.E., Langer, K., Berthold, A., Kharkevich, D.A. and Kreuter, J. (1997) Delivery of loperamide across the blood-brain-barrier with polysorb 80-coated polybutylcyanoacrylate nanoparticles. Pharm. Res., 14: 325-328.
3. Backlund, E.O., Neal, J.H., Waters, C.H., Appley, A.J., Boyd, S.D., Couldwell, W.T., Wheelock, V.H. and Weiner, L.P. (1985) Transplantation of adrenal medullary tissue to striatum in parkinsonism; first clinical trials. J. Neurosurg., 62: 169-173.
4. Bankiewicz, K.S., Bringas, J.R., McLaughlin, W.W., Pivirotto, P., Hundal, R., Emborg, M.E. and Nagy, D. (1998) Application of gene therapy for Parkinson's disease: Nonhuman primate experience. Adv. Pharmacol., 42: 801-806.
5. Barker, R.A., Ratcliffe, E., Richards, A. and Dunnett, S.B. (1999) Fetal porcine dopaminergic cell survival in vitro and its relationship to embryonic age. Cell Transplant., 8: 593-599.
6. Bartus, R.T., Elliot, P., Dean, R.L., Hayward, N.J., Nagle, T.L., Huff, M.R., Snodgras, P.A, and Blunt, D.G. (1996a) Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7. Exp. Neurol., 142: 14-28.
7. Bartus, R.T., Elliott, P., Hayward, N., Dean, R. and Fisher, S. (1996b) Permeability of the BBB by the B2 agonist RMP-7: Evidence for a sensitive, autoregulated, receptor-mediated system. Immunopharmacology, 33: 270-278.
8. Björklund, A. and Stenevi, U. (1979) Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res., 177: 555-560.
9. Björklund, A. and Stenevi, U. (1985) Intracerebral neural grafting. In: Björklund, A. and Stenevi, U. (Eds.), Neural Grafting in the Mammalian CNS. Elsevier, Amsterdam, pp. 3-14.
10. Björklund, A., Lindvall, O., Isacson, O., Brundin, P., Wictorin, K., Strecker, R.E., Clarke, D.J. and Dunnett, S.B. (1987) Mechanisms of action of intracerebral neural implants: Studies on nigral and striatal grafts to the lesioned striatum. Trends Neurosci., 10: 509-516.
11. Bohn, M.C., Choi-Lundberg, D.L., Davidson, B.L., Leranth, C., Kozlowski, D.A., Smith, J.C., O'Banion, M.K. and Redmond Jr., D.E. (1999) Adenovirus-mediated transgene expression in nonhuman primate brain. Hum. Gene Ther., 10: 1175-1184.
12. Brem, H., Mahaley Jr., M.S., Vick, N.A., Black, K.L., Schold Jr., S.C., Burger, P.C., Friedman, A.H., Ciric, I.S., Eller, TW., Cozzens, J.W. and Kenealy, J.N. (1991) Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J. Neurosurg., 74: 44144-44146.
13. Broadwell, R.D., Baker-Cairns, B.J., Friden, P.M., Oliver, C. and Villegas, J.C. (1996) Transcytosis of protein through the mammalian cerebral epithelium and endothelium, III. Receptor-mediated transcytosis through the blood-brain barrier of blood borne transferrin and antibody against the transferrin receptor. Exp. Neurol., 142: 47-65.
14. Brustle, O. and McKay, R.D. (1996) Neuronal progenitors as tools for cell replacement in the nervous system. Curr. Opin. Neurobiol., 6: 688-695.
15. Carvey, P.M., Maag, T.J. and Lin, D. (1994) Injection of biologically active substances into the brain. In: Flanagan, T.R., Emerich, D.F. and Winn, S.R. (Eds.), Providing Pharmacological Access to the Brain: Alternate Approaches. Methods in Neurosciences, Vol. 21, Academic Press, San Diego, CA, pp. 214-233.
16. Choi-Lundberg, D.L., Bohn and M.C., 1998. Applications of gene therapy to neurological diseases and injuries. In: Quesenberry, P.J., Stein, G.S., Forget, B. and Weissman, S. (Eds.), Stem Cell Biology and Gene Therapy. Wiley, New York, pp. 503-553.
17. Daniel, P.M., Moorhouse, S.R. and Pratt, O.E. (1976) Do changes in blood levels of other aromatic amino acids influence levodopa therapy?. Lancet, 1: 95.
18. Date, I., Ohmoto, T., Imaoka, T., Ono, T., Hammang, J.P., Francis, J. and Greco, C. (1996) Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats. J. Neurosurg., 84: 1006-1012.
19. Davidson, B.L., Doran, S.E., Shewach, D.S., Latta, J.M., Hartman, J.W. and Roessler, B.J. (1994) Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer. Exp. Neurol., 125: 258-267.
20. Duffy, K.R. and Pardridge, W.M. (1987) Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res., 420: 32-38.
21. Duffy, K.R., Pardridge, W.M. and Rosenfeld, R.G. (1988) Human blood-brain barrier insulin-like growth factor receptor. Metabolism, 37: 136-140.
22. Ebendal, T., Lonnerberg, P., Pei, G., Kylberg, A., Kullander, K., Persson, H. and Olson, L. (1994) Engineering cells to secrete growth factors. J. Neurol., 242: S5-S7.
23. Emborg, M.E. and Colombo, J.A. (1994) Long-term MPTP-treated monkeys are resistant to GM1 systemic therapy. Mol. Chem. Neuropathol., 21: 75-82.
24. Emborg, M.E., Shin, P., Roitberg, B., Sramek, J.G., Chu, Y., Stebbing, G., Hamilton, J.S., Suzdak, P.D., Steiner, J.P. and Kordower, J.H. (2000) Systemic Administration of the Immunophilin Ligand GPI 1046 in MPTP Treated Monkeys. In revision.
25. Emerich, D.F., Bruhn, S., Chu, Y. and Kordower, J.H. (1998a) Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease. Cell Transplant., 7: 213-225.
26. Emerich, D.F., Winn, S.R., Hantraye, P.M., Peschanski, M., Chen, E.-Y., Chu, Y., McDermott, P., Baetge, E.E. and Kordower, J.H. (1998b) Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature, 386: 395-399.
27. Eriksdotter-Jonhagen, M., Nordberg, A., Amberla, K., Backman, L., Ebendal, T., Meyerson, B., Olson, L., Seiger, A., Shigeta, M., Theodorsson, E., Viitanen, M., Winblad, B. and Wahlund, L.O. (1998) Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord., 9: 246-257.
28. Espejo, E.F., Montoro, R.J., Armengol, J.A. and Lopez-Barneo, J. (1998) Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron, 20: 197-206.
29. Freed, C.R., Breeze, R.E., Rosenberg, N.L., Schneck, S.A., Kriek, E., Qi, J.X., Lone, T., Zhang, Y.B., Snyder, J.A. and Wells, T.H. (1992) Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation in Parkinson's disease. N. Engl. J. Med., 327: 1549-1555.
30. Freed, W.J., Morihisa, J.M., Spoor, E., Hoffer, B.J., Olson, L., Seiger, A. and Wyatt, R.J. (1981) Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour. Nature, 292: 351-352.
31. Freed, W.J., Poltorack, M. and Becker, J.B. (1990) Intracerebral adrenal medulla grafts: A review. Exp. Neurol., 110: 139-166.
32. Friden, P.M., Walus, L.R., Musso, G.F., Taylor, M.A., Malfroy, B. and Starzyk, R.M. (1991) Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc. Natl. Acad. Sci. USA, 88: 4771-4775.
33. Friedrich, M.J. (1999) Fetal pig neural cells for Parkinson disease. JAMA, 282: 2198-2199.
34. Gage, F.H., Ray, J. and Fisher, L.J. (1995) Isolation, characterization, and use of stem cells from the CNS. Annu. Rev. Neurosci., 18: 159-192.
35. Granholm, A.C., Backman, C., Bloom, F., Ebendal, T., Gerhardt, G.A., Hoffer, B., Mackerlova, L., Olson, L., Soderstrom, S., Walus, L.R. and Friden, P.M. (1994) NGF and anti-transferrin receptor antibody conjugate: Short and long-term effects on survival of cholinergic neurons in intraocular septal transplants. J. Pharmacol. Exp. Ther., 268: 448-459.
36. Gregoriadis, G., Senior, J., Wolff, B. and Kirby, M.C. (1985) Targeting of liposomes to accessible cells in vivo. Ann. N.Y. Acad. Sci., 446: 319-340.
37. Habeck, M. (2000) Xenotransplanted neurons show potential to treat spinal injuries and Parkinson's disease. Mol. Med. Today, 6: 46-47.
38. Huwyler, J., Wu, D. and Pardridge, W.M. (1996) Brain drug delivery of small molecules using immunoliposomes. Proc. Natl. Acad. Sci. USA, 93: 14164-14169.
39. Inamura, T., Nomura, T., Bartus, R.T. and Black, K.L. (1994) Intracarotid infusion of RMP-7, a bradykinin analog: A method for selective drug delivery to brain tumors. J. Neurosurg., 81: 752-758.
40. Jeffries, W.A., Brandon, M.R., Hunt, S.V., Williams, A.F., Gatter, K.C. and Mason, D.Y. (1984) Transferrin receptor on endothelium of brain capillaries. Nature, 312: 162-163.
41. Kang, Y.S. and Pardridge, W.M. (1994) Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin. Pharmacol. Res., 11: 1257-1264.
42. Kordower, J.H., Charles, V., Bayer, R., Bartus, R.T., Putney, S., Walus, L.R. and Friden, P.M. (1994) Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents degeneration of cholinergic striatal neurons in a model of Huntington's disease. Proc. Natl. Acad. Sci. USA, 91: 9077-9088.
43. Kordower, J.H., Freeman, T.B., Snow, B.J., Vingerhoets, F., Mufson, E.J., Sanberg, P.R., Hauser, R.A., Smith, D.A., Nauert, G.M., Perl, D.P. and Olanow, C.W. (1995a) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med., 332: 1118-1124.
44. Kordower, J.H., Liu, Y.-T., Winn, S. and Emerich, D.F. (1995b) Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: A behavioral, neuroanatomical and neurochemical analysis. Cell Transplant., 4: 155-171.
45. Kordower, J.H., Chen, E.-Y., Winkler, C., Fricker, R., Charles, V., Messing, A., Mufson, E., Woing, S.C., Rosenstein, J.M., Björklund, A., Emerich, D., Hammang, J. and Carpenter, M.K. (1997) Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: Trophic and tropic effects in a rodent model of Huntington's disease. J. Comp. Neurol., 387:96-113.
46. Kordower, J.H., Chen, E.-Y., Mufson, E.J., Winn, S.R. and Emerich, D.F. (1998) Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: Trophic effects upon cholinergic and noncholinergic striatal neurons. Neuroscience, 72: 63-77.
47. Kordower, J.H., Palfi, S., Chen, E.-Y., Ma, S., Sendera, T., Cochran, E.J., Mufson, E.J., Penn, R., Goetz, C. and Comella, C.D. (1999a) Clinico-pathological findings following intraventricular GDNF treatment in a patient with Parkinson's disease. Ann. Neurol., 46: 419-424.
48. Kordower, J.H., Isacson, O. and Emerich, D.F. (1999b) Cellular delivery of trophic factors for the treatment of Huntington's disease: Is neuroprotection possible?. Exp. Neurol., 159: 4-20.
49. Kordower, J.H., Bloch, J., Chu, Y.P., Palfi, S., Roitberg, B., Emborg, M.E., Hantraye, P., Deglon, N. and Aebischer, P. (1999c) Lentiviral gene transfer to the non-human primate nigrostriatal system. Exp. Neurol., 160: 1-16.
50. Kubo, O., Himuro, H., Inoue, N., Tajika, Y., Tajika, T., Tohyama, T., Sakairi, M., Yoshida, M., Kaetsu, I. and Kitamura, K. (1986) Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites. No Shinkei Geka, 14: 1189-1195.
51. Kumagai, A.K., Eisenberg, J.B. and Pardridge, W.M. (1989) Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J. Biol. Chem., 262: 15214-15219.
52. Lapchak, P.A. (1993) Nerve growth factor pharmacology: Application to the treatment of cholinergic neurodegeneration in Alzheimer's disease, Exp. Neurol., 124: 16-20.
53. Lapchak, P.A., Jiao, S., Miller, P.J., Williams, L.R., Cummins, V., Inouye, G., Matheson, C.R. and Yan, Q. (1996) Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): Implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases. Cell Tissue Res., 286: 179-189.
54. Lapchak, P.A., Jiao, S.S., Collins, F. and Miller, P.J. (1997) Glial cell line-derived neurotrophic factor: Distribution and pharmacology in the rat following a bolus intraventricular injection. Brain Res., 747: 92-102.
55. Luquin, M.R., Montoro, R.J., Guillen, J., Saldise, L., Insausti, R., Del Rio, J. and Lopez-Barneo, J. (1999). Neuron, 22: 743-750.
56. Madrazo, I., Drucker-Colin, R., Diaz, V., Martinez-Mata, J., Torres, C. and Becerril, J.J. (1987) Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N. Engl. J. Med., 316: 831-834.
57. McRae-Degueurce, A., Hjorth, S., Dillon, D.L., Mason, D.W. and Tice, T.R. (1988) Implantable microencapsulated dopamine (DA): A new approach for slow-release DA delivery into brain tissue, Neurosci. Lett., 92: 303-309.
58. Menei, P., Boisdron-Celle, M., Croue, A., Guy, G. and Benoit, J.P. (1996) Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery, 39: 117-123.
59. Nakao, N., Itakura, T., Uematsu, Y. and Komai, N. (1995) Transplantation of cultured sympathetic ganglionic neurons into parkinsonian rat brain: Survival and function of graft. Acta Neurochir. (Wien), 133: 61-67.
60. Nutt, J.G. and Fellman, J.H. (1984) Pharmacokinetics of levodopa. Clin. Neuropharmacol., 7: 35-49.
61. Oda, Y., Uchida, Y., Murata, T., Mori, K., Tokuriki, Y., Handa, H., Kobayashi, A., Hashi, K. and Kieler, J. (1982) Treatment of brain tumors with anticancer pellet - Experimental and clinical study. No Shinkei Geka, 10: 375-381.
62. Oldendorf, W.H. (1971) Brain uptake of radiolabeled amino acids, amines and hexoses after arterial injection. Am. J. Physiol., 221: 1629-1639.
63. Olson, L. (1993) NGF and the treatment of Alzheimer's disease. Exp. Neurol., 124: 5-15.
64. Olson, L., Backman, L., Ebendal, T., Eriksdotter-Jonhagen, M., Hoffer, B., Humpel, C., Freedman, R., Giacobini, M., Meyerson, B. and Nordberg, A. (1994) Role of growth factors in degeneration and regeneration in the central nervous system: Clinical experiences with NGF in Parkinson's and Alzheimer's diseases. J. Neurol., 242: S12-S15.
65. Pardridge, W.M., Triguero, D. and Buciak, J. (1989) Transport of histone through the blood-brain barrier. Pharmacol. Exp. Ther., 251: 821-826.
66. Pardridge, W.M., Kang, Y.S. and Buciak, J.L. (1994) Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharmacol. Res., 11: 738-746.
67. Penn, R.D., Kroin, J.S., Reinkesmeyer, A. and Corcos, D. (1998) Injection of GABA-agonist into globus pallidus in patient with Parkinson's disease. Lancet, 351: 340-341.
68. Riachi, N.J. and Harik, S.I. (1992) Monoamine oxidases of the brains and livers of macaque and cercopithecus monkeys. Exp. Neurol., 115: 212-217.
69. Robbins, P.D. and Ghivizzani, S.C. (1998) Viral vectors for gene therapy. Pharmacol. Ther., 80: 35-47.
70. Sakane, T., Yamashita, S., Yata, N. and Sezaki, H. (1999) Transnasal delivery of 5-fluorouracil to the brain in the rat. J. Drug Target, 7: 233-240.
71. Sanovich, E., Bartus, R.T., Friden, P.M., Dean, R.L., Le, H.Q. and Brightman, M.W. (1995) Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7. Brain Res., 705:125-135.
72. Schneider, J.S., Roeltgen, D.P., Mancall, E.L., Chapas-Crilly, J., Rothblat, D.S. and Tatarian, G.T. (1998) Parkinson's disease: Improved function with GM1 ganglioside treatment in a randomized placebo-controlled study. Neurology, 50: 1630-1636.
73. Schwarting, R.K.W. and Huston, J.P. (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog. Neurobiol., 50: 275-331.
74. Sendelbeck, S.L. and Urquhart, J. (1985) Spatial distribution of dopamine, methotrexate, and antipyrine during continuous intracerebral microperfusion. Brain Res., 328: 251-258.
75. Seventh International Meeting on Neural Transplantation and Repair (2000). Exp. Neurol., 161: 397-431.
76. Sladek Jr., J.R. and Gash, D.M. (1988) Nerve cell grafting in Parkinson's disease. J. Neurosurg., 68: 337-351.
77. Stromberg, I., Herrera-Marschitz, M., Ungerstedt, U., Ebendal, T. and Olson, L. (1985) Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior. Exp. Brain Res., 60: 335-349.
78. Svendsen, C.N. (1997) Neural stem cells for brain repair. Alzheimer's Res., 3: 131-135.
79. Triguero, D.J., Buciak, B., Yang, J. and Pardridge, W.M. (1989) Blood-brain-barrier transport of cationized immunoglobulin G. Enhanced delivery compared to native protein. Proc. Natl. Acad. Sci. USA, 86: 4761-4765.
80. Tsuzuki, N., Hama, T., Hibi, T., Konishi, R., Futaki, S. and Kitagawa, K. (1991) Adamantane as a brain-directed drug carrier for poorly absorbed drug: Anti-nociceptive effects of [D-Ala2] leu-enkephalin derivatives conjugated with 1-adamantane moiety. Biochem. Pharmacol., 41: R5-R8.
81. Verma, I.M. and Somia, N. (1997) Gene therapy - Promises, problems and prospects. Nature, 389: 239-242.
82. Wim, T.J., Hermens, M.C. and Verhaagen, J. (1998) Viral vectors, tools for gene transfer in the nervous system. Prog. Neurobiol., 55: 399-432.
83. Yurek, D.M. and Sladek Jr., J.R. (1990) Dopamine cell replacement: Parkinson's disease. Annu. Rev. Neurosci., 13: 415-440.
84. Zawada, W.M., Cibelli, J.B., Choi, P.K., Clarkson, E.D., Golueke, P.J., Witta, S.E., Bell, K.P., Kane, J., Ponce de Leon, F.A., Jerry, D.J., Robl, J.M., Freed, C.R. and Stice, S.L. (1998) Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats. Nat. Med., 4: 569-574.
85. Zigmond, M.J., Abercrombie, E.D., Berger, T.W., Grace, A.A. and Stricker, E.M. (1990) Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications. Trends Neurosci., 13: 290-296.